Johnson & Johnson (J&J, NYSE: JNJ), a global healthcare giant, has announced the appointment of Edward Zhou as President of its Medtech division in China, effective from July 25, 2024. Zhou will report to Vishnu Karla, Chairman of Johnson & Johnson Medtech Asia Pacific. This strategic appointment comes at a time when the company is looking to strengthen its leadership in the Chinese medical technology market.
Edward Zhou brings nearly three decades of experience with Johnson & Johnson to his new role. He began his journey with the company in 1992, starting in the consumer business sector. Zhou’s tenure with the company includes a stint as General Manager of the Singapore office and a significant role in the acquisition of the DABAO skincare brand in China, where he served as General Manager for three years. His leadership in the company’s Ethicon business unit in China began in 2015, when he was appointed Vice President, and he was promoted to General Manager in 2016.
Johnson & Johnson Medtech has been a presence in China since 1994, focusing on surgical, orthopedic, cardiovascular, and professional solutions fields. The division has been instrumental in bringing innovative medical technologies and solutions to the Chinese market, contributing to the advancement of healthcare in the country.
Zhou’s appointment as President of J&J Medtech China is a testament to his leadership skills and deep understanding of the company’s operations and strategy. His extensive experience within the company and his proven track record in managing business units position him well to drive growth and innovation for J&J Medtech in China.
As the new President, Edward Zhou will be responsible for steering the company’s medtech business in China, overseeing operations, and ensuring that J&J continues to deliver on its commitment to improve patient outcomes through cutting-edge medical technologies. His leadership is expected to play a pivotal role in shaping the future of J&J Medtech in the Chinese market, which is a key growth engine for the company’s Asia Pacific operations. -Fineline Info & Tech
